SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 142 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $709,113 | -64.3% | 30,671 | -59.5% | 0.00% | -100.0% |
| Q2 2023 | $1,983,936 | +38.4% | 75,665 | +35.9% | 0.00% | 0.0% |
| Q1 2023 | $1,433,409 | -64.2% | 55,688 | -63.8% | 0.00% | -50.0% |
| Q4 2022 | $4,000,729 | +31.1% | 153,815 | +43.9% | 0.00% | 0.0% |
| Q3 2022 | $3,051,000 | +15.5% | 106,924 | -0.4% | 0.00% | +100.0% |
| Q2 2022 | $2,642,000 | -55.4% | 107,311 | +2.2% | 0.00% | -66.7% |
| Q1 2022 | $5,929,000 | -10.0% | 105,039 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $6,585,000 | -8.2% | 106,251 | -6.1% | 0.00% | 0.0% |
| Q3 2021 | $7,176,000 | -18.0% | 113,128 | +6.6% | 0.00% | -25.0% |
| Q2 2021 | $8,749,000 | +76.2% | 106,161 | +57.3% | 0.00% | +33.3% |
| Q1 2021 | $4,966,000 | +262.2% | 67,504 | +257.2% | 0.00% | +200.0% |
| Q4 2020 | $1,371,000 | +130.8% | 18,899 | +51.5% | 0.00% | – |
| Q3 2020 | $594,000 | +31.7% | 12,472 | +16.4% | 0.00% | – |
| Q2 2020 | $451,000 | +360.2% | 10,718 | +195.5% | 0.00% | – |
| Q1 2020 | $98,000 | -33.3% | 3,627 | -5.5% | 0.00% | – |
| Q4 2019 | $147,000 | – | 3,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |